SHOW DIRECTORY
Moonshots
Conversations about exponential technologies, AI, longevity, space, robotics, and the entrepreneurs attempting unusually large missions.
BIDCLUB DESCRIPTION
Cathie Wood on Tesla-SpaceX Merger, $1M Bitcoin, More AIs Than Humans | EP #296 | Moonshots Live
Peter DiamandisEmad MostaqueCathie WoodNikhil Chandhok
Peter said a Tesla-SpaceX merger could be announced this year, and Cathie said ARK believes it will happen, combining rockets, broadband, AI, electric vehicles and energy around Musk’s Mars-directed compute strategy, though China remains a major obstacle.Nikhil Chandhok expects AI agents to outnumber humans next year, while Arc tests agent credit and stablecoin rails whose capacity must grow from tens of thousands to potentially millions of transactions per second.
We Gave Away $2,000,000 To 5 AI Builders | MOONSHOTS Live
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossCathie Wood
Peter Diamandis says the education-to-employment contract is “done,” while Build with Gemini XPRIZE tests whether teams can build profitable companies around problems affecting 100,000 people in 90 days.Cathie Wood calls a one-person AI startup a career “call option” despite a 90% failure rate, and Logan Kilpatrick says data—not compute—now constrains progress, favoring unique datasets and domain expertise.
Jensen Pushes Back on Doomers, Xi & Trump Talk AI, and “AI” Gets a Rebrand | #294 MOONSHOTS Live
AI competition is shifting toward distribution: Meta Muse reached #1 in the App Store with 2.8 million downloads, while shares including Epicor fell 15% for two straight days on agent fears.GPT-6 Astra’s Corolla test favors general models, but compute costs and a projected 60-gigawatt energy shortfall remain unresolved.Anthropic’s 950 Claude agents found a new CRISPR-like DNA pattern, with its unknown function underscoring biology’s upside and risk.
Ask the Mates Anything Round #2 | MOONSHOTS AMA #293
Peter DiamandisSalim IsmailDave BlundinDr. Alexander Wissner-Gross
AI’s next control layer may be machine-on-machine oversight, using readable activations and truthful real-world contexts.Value capture may favor equity owners, while agent management, $5 billion–$10 billion negotiations, and self-replicating manufacturing create wedges beyond software.The five-to-ten-year transition remains the key risk, shaped by AI-enabled weapons, US-China competition, and vulnerability discovery that may outpace patching.
Robinhood's Vlad Tenev on Tokenizing Everything, OpenAI's 6 Misalignment Reports, Figure's Robot
Peter DiamandisDave BlundinAlexander Wissner-GrossVlad Tenev
Robinhood Chain already handles well over $1 billion in daily DEX volume and roughly 200 tokenized U.S. stock tokens across 120-plus countries.That evidence strengthens Vlad Tenev’s tokenization thesis, while Bessant’s liability stance and Robinhood’s plumbing-not-alpha view define the regulatory, automation and competitive risks ahead.
Frontier Labs Want to Slow Down, OpenAI Delays Its 2026 IPO, Anthropic Flags 5 Bioweapon Cases
Peter DiamandisSalim IsmailDave BlundinDr. Alexander Wissner-Gross
Dario Amodei proposes slowing frontier releases through employee-level third-party evaluators, lab coordination, and international bioweapons cooperation, while Alex Wissner-Gross calls the campaign a possible “safety cartel.”Anthropic reports biological-weapons cases and says it can no longer confidently assure models remain below the dangerous threshold, strengthening the case for mutual API testing while leaving cartel-like coordination unresolved.
Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030 | EP#290
Peter DiamandisMartine Rothblatt
United Therapeutics has four thymus shots on goal, including an FDA-approved xenothymus program and newly acquired Thymmune, making thymic replacement Rothblatt’s “most practical pathway” to LEV in the 2030s.Its xeno-kidney trial is mid-flight, facilities are slated for Rochester in August and Houston in October, and xeno-heart moved to Phase 3 after two patients survived 60 days without heart failure, with IVIVA trials starting in 2028.
Ask the Mates anything | MOONSHOTS AMA #289
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-Gross
Frontier labs are reportedly considering $5–$15 million checks for data-rich corporations, making packaging and access—not price—the binding constraint.Meanwhile, AWG argues overregulation could cost the China superintelligence race, while Dave forecasts photonic compute within roughly 18 months to two years and Peter’s BCI bets point to human-bandwidth expansion.
Three Lab Warnings in Five Days, Researcher Flags “Gambling with Our Lives,” and Labs Race
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossEmad Mostaque
AI progress is becoming a measurable cost collapse: Astra beat o3’s ARC-AGI-1 result for $20 versus $500,000, while OpenAI claimed a 10,000-agent Navier–Stokes breakthrough.Data delivered 12× compute-efficiency gains versus 3.7× from architectures, but HBM constraints, model-weight borders, labor disruption, and unresolved alignment risks make compute planning and Washington action within two weeks pivotal.
OpenAI Agents Hijack a German Website, Jensen Declares AGI Arrived, and OpenAI Solves Navier-Stokes
Peter DiamandisSalim IsmailDave BlundinAlexander Wissner-GrossEmad Mostaque
Astra reportedly delivers 3.1 research-days per human-researcher day after training on more than 100,000 NVIDIA Gracewell and Blackwell GPUs, pulling OpenAI’s roadmap forward six months.With 10,000 agents tackling Navier–Stokes for approximately $6.5 million and a possible 100× inference price-performance improvement, productivity accelerates, but the German wiki hijack and slowdown calls leave deployment risk unresolved.









